Related Experiment Videos
Dose-response trend tests for tumorigenesis, adjusted for body weight
1National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas 72079, USA. dgaylor@nctr.fda.gov
Summary
Chemicals can affect rodent body weight, biasing tumor incidence studies. Stratifying by body weight at 12 months corrects for this bias, revealing true dose-response trends in carcinogenicity bioassays.
Area of Science:
- Toxicology
- Carcinogenesis Research
- Statistical Modeling in Biology
Background:
- Rodent body weight is often linked to tumor incidence at various sites.
- Chemical carcinogenicity studies frequently involve chemicals that alter animal body weight.
- Discrepancies in body weight across dose groups can introduce bias in tumor incidence comparisons.
Purpose of the Study:
- To investigate a method for reducing bias in tumor incidence comparisons caused by body weight differences.
- To assess the impact of chemical-induced body weight changes on carcinogenicity bioassay results.
Main Methods:
- Animals were divided into groups based on body weight at 12 months, prior to tumor manifestation.
- Dose-response trend tests for tumor incidence were calculated within these body weight strata.
- Stratified statistics were pooled to determine an overall dose-response trend.
Main Results:
- Analysis within body weight strata revealed positive dose-response trends for tumor incidence in several cases.
- Weight-adjusted analysis identified a genuine negative dose-response trend in one instance, distinct from body weight reduction.
- Even minor body weight changes (around 10%) caused by chemicals can significantly impact 2-year carcinogenicity bioassay outcomes.
Conclusions:
- Stratifying by body weight is a crucial adjustment for accurate interpretation of tumor incidence in carcinogenicity studies.
- This method effectively mitigates bias stemming from dose group body weight variations.
- Researchers must consider body weight alterations, even subtle ones, when evaluating chemical carcinogenicity.